'Ra patients' diaporamas de présentation

29 November 2006

FDA Advisory Committee Meeting. 29 November 2006. Celecoxib in the Treatment of the Signs and Symptoms of Juvenile Rheumatoid Arthritis (JRA). Delegation. Objectives. To highlight the medical need for NSAIDs in the treatment of children with JRA.

1.15k views • 91 slides

OPM Session #10

OPM Session #10. Kathy Molnar- Kimber Homework www.Rheumatoid-Arthritis-Decisions.com. Audience : People with Rheumatoid Arthritis (RA), family, care givers, maybe healthcare or social workers that work with RA patients.

1.03k views • 89 slides

Update: Rheumatoid Arthritis

A C R / A R H P 2 0 0 8. Update: Rheumatoid Arthritis. ACR/ARHP 2008 : Update on Rheumatoid Arthritis.

997 views • 87 slides

Clinical features and research opportunities in rheumatoid arthritis

Clinical features and research opportunities in rheumatoid arthritis. Clinical Immunology March 26, 2013. HARVARD MEDICAL SCHOOL. Overview. Clinical characteristics and pathophysiology Differential diagnosis Exam and laboratory studies Treatment strategy Research opportunities. Overview.

1.01k views • 74 slides

Efficacy and Safety of Tocilizumab in the Treatment of Rheumatoid Arthritis

New Evidence reports on presentations given at EULAR 2010. Efficacy and Safety of Tocilizumab in the Treatment of Rheumatoid Arthritis and Juvenile Idiopathic Arthritis. Report on EULAR 2010 presentations.

1.05k views • 70 slides

880 views • 68 slides

Square wheels: electronic medical records for discovery research in rheumatoid arthritis

Square wheels: electronic medical records for discovery research in rheumatoid arthritis. ^ genetic. Robert M. Plenge, M.D., Ph.D. October 30, 2009 NCRR sponsored " Using EHR Data for Discovery Research ". HARVARD MEDICAL SCHOOL. Key questions.

789 views • 64 slides

950 views • 60 slides

Update in Rheumatoid Arthritis

Update in Rheumatoid Arthritis. Gregory Gardner, M.D. Gilliland-Henderson Professor of Medicine Division of Rheumatology University of Washington. Outline of Discussion. Pathophysiology Clinical Features Treatment Update Perioperative Management. Rheumatoid Arthritis. Pathophysiology.

1.24k views • 58 slides

Patient Questionnaires Tutorial: Review of MDHAQ and score RAPID3

Patient Questionnaires Tutorial: Review of MDHAQ and score RAPID3. Theodore Pincus MD Clinical Professor of Medicine New York University tedpincus@gmail.com. Complexities in quantitative assessment of patients with RA and rheumatic diseases.

671 views • 44 slides

594 views • 40 slides

Overview

Safety & Tolerability of Biologics Dubai, United Arab Emirates January 19th, 2009 Prof. Joachim R. Kalden Director emeritus Department of Internal Medicine III Div. of Molecular Immunology Niklolaus-Fiebiger-Center University of Erlangen-Nuremberg. Overview. Monitoring of safety: registries

544 views • 39 slides

Outline

Expanding the Research Domains of Rheumatoid Arthritis Clinical Databases: The Promise of Pharmacogenetics Jeffrey Greenberg, MD, MPH NYU Hospital for Joint Diseases New York University School of Medicine December 2006. Outline. Why Pharmacogenetics Case Study: TNF Antagonists

474 views • 37 slides

Identifying RA patients from the electronic medical records at Partners HealthCare

Identifying RA patients from the electronic medical records at Partners HealthCare. Robert Plenge, M.D., Ph.D. VA Hospital July 20, 2010. HARVARD MEDICAL SCHOOL. genotype. phenotype. clinical care. genotype. bottleneck. phenotype. clinical care. July 2010: > 30 RA risk loci.

420 views • 35 slides

Autologous Serum Eye Drops: Fact or Fiction?

Autologous Serum Eye Drops: Fact or Fiction?. Grand Rounds March 2005 Jay C. Bradley, MD Sandra M. Brown, MD. Nutrition of the Ocular Surface. Aqueous Glucose Electrolytes Amino acids Lacrimal gland Growth factors Vitamins Conjunctival vessels Neuropeptides Lactoferrin

656 views • 24 slides

300 views • 20 slides

Rheumatoid Arthritis (RA)

482 views • 19 slides

598 views • 11 slides

MabThera retreatment in RA The Belgian perspective

MabThera retreatment in RA The Belgian perspective. Professor Filip DE KEYSER Royal Belgian Society of Rheumatology Aalst 2007. Topics. Efficacy & safety of rituximab retreatment in RA patients Belgian criteria for rituximab retreatment in RA patients

393 views • 9 slides

????????????????

????????????????. Temporomandibular joint disorders in patients with rheumatoid arthritis.

115 views • 2 slides